Med-Tech Innovation November 16, 2023
Dr James Graveston, a senior medtech specialist at Zühlke UK and former NHS hospital doctor, explores research UK consumers have towards apps and other digital services, why they are the future – but with insights on the problems B2C firms will need to overcome if they are planning to scale successfully with sales to consumers.
Our conclusion for medtech providers going down the B2C route with a purely digital solution is they must be very cautious indeed about revenue expectations. There really isn’t a clear remuneration pathway
There is some good news for medtech CEOs and entrepreneurs from our research this year into UK adults and their attitudes towards medical apps and other digital treatments… but sadly a lot of...